Trials / Terminated
TerminatedNCT00979940
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After PCI
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This research study plans to evaluate the use of atorvastatin in patients with coronary artery disease given immediately before PCI and whether it will decrease the amount of heart damage after PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | Atorvastatin 80mg po given one time before PCI in cath lab. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2014-06-01
- Completion
- 2014-08-01
- First posted
- 2009-09-18
- Last updated
- 2015-09-22
- Results posted
- 2015-09-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00979940. Inclusion in this directory is not an endorsement.